Accortt et al. [7] showed a similar result in patients receiving TNF-inhibitor treatment for rheumatic conditions, including RA, psoriatic arthritis, ankylosing spondylitis, and psoriasis. This evidence concerns the gene TNF and rheumatoid arthritis.